ImmunityBio, Inc.IBRXNASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-308.01M
↓ 30% vs avg
Percentile
P25
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-236.21M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-308.01M | +22.6% |
| 2024 | $-398.12M | -0.2% |
| 2023 | $-397.34M | +4.4% |
| 2022 | $-415.67M | -35.0% |
| 2021 | $-307.98M | -77.6% |
| 2020 | $-173.39M | -10.9% |
| 2019 | $-156.40M | -104.5% |
| 2018 | $-76.48M | +8.5% |
| 2017 | $-83.59M | -85.1% |
| 2016 | $-45.15M | - |